Avelumab (MSB0010718C), an anti-PD-L1 antibody, as a third-line treatment in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib JAVELIN Solid Tumor trial.
JOURNAL OF CLINICAL ONCOLOGY. Bd. 34. H. 4. 2016
Erscheinungsjahr: 2016
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Oh, Do-Youn (Autor)
Lockhart, Albert C. (Autor)
Wong, Deborah Jean Lee (Autor)
Taylor, Matthew Hiram (Autor)
Bajars, Marcis (Autor)
von Heydebreck, Anja (Autor)
Moehler, Markus H. (Autor)
Safran, Howard (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
